I ran an RNA-seq experiment and used TopHat> cufflink It is a time series experiment when I looked at RPKM values in some of the transcripts the RPKM values goes upto 32765.04908; 2073.978485 . Is is reasonable? I also looked at Bam files there weresecrtainly very large number of reads. Any feedback/ suggestion please how to explain this high RPKM values?
Unconfigured Ad
Collapse
X
-
I think that these values should be taken to the log(10).. this is not documented, but my suspicion.Originally posted by honey View PostI ran an RNA-seq experiment and used TopHat> cufflink It is a time series experiment when I looked at RPKM values in some of the transcripts the RPKM values goes upto 32765.04908; 2073.978485 . Is is reasonable? I also looked at Bam files there weresecrtainly very large number of reads. Any feedback/ suggestion please how to explain this high RPKM values?
log(10) values from cufflinks roughly equals FPKM values from cuffdiff..
-
-
very high RPKM values from 4.5 to sevreal thousands
Howver the problem which I have is that the RPKM are high apx. 5% are > 1000RPKM (like 3245, 4356 and so on) in the same sample. If I change to log 10 than then what will happen to values around zero. Is it a usual method to log transform RPKM value?
Any feedback is welcome
Thanks
Comment
-
-
Honey, I could be totally wrong here about the log(10) thing, but I don't think I am..
Can you look at the mappings for some of those transcripts where 'raw' FPMK is about 0-- do they have few reads mapped?
See:
Comment
-
-
High RPKM
Thanks I looked at the Bam files and can say that there are very few reads wherver it is 0 values of RPKM however where the values are very high those are the kind of hot spots there are large no of reads. Now the question is is this an artifact -High RPKM or very low RPKM how we rope up both extreme values?
Comment
-
-
honey, it might be a good idea to look a bit more in depth into that specific gene. You can certainly get high FPKMs mapping to genes like actin that make up a lot of the mRNA percentage of a cell. I had huge numbers of reads mapping to one region of a miRNA gene once that all turned out to be within a LINE and a SINE. For that gene at least, it was clear the repeat regions skewed the results.
Comment
-
-
very large RPKM
It is human genome so it is not small.
The egnes which have very high RPKM values are relavnt to biology of the tissue samples, but my problem is how to provide a scientific rational that our results are not nonspecific.
Thanks for the input
Comment
-
-
That does not make sense to me. Unless it is an option in either Cufflinks or Cuffdiff, but I have never saw a log relationship between Cufflinks and Cuffdiff outputs.Originally posted by peromhc View PostI think that these values should be taken to the log(10).. this is not documented, but my suspicion.
log(10) values from cufflinks roughly equals FPKM values from cuffdiff..
Honey, how did you run Cufflinks? RABT mode or simple "quantification" mode? How long are the genes with super-high RPKM?
It seems to me that Cufflinks has a tendency to report super-high RPKM for very short transcripts (such as microRNA). I now routinely filter out the transcripts shorter than the expected fragment size (from the GTF annotation file). I think there is a good rationale to filter them out, because they can not be accurately captured by the RNA-Seq protocol....
In RABT mode, Cufflinks also reports a large number of short transcripts with crazy high values. A solution could be to re-quantify the discovered transcripts with something like BEDtools or HTSeq-count...
Comment
-
-
High RPKM
I used simple quantificationOriginally posted by Nicolas View PostThat does not make sense to me. Unless it is an option in either Cufflinks or Cuffdiff, but I have never saw a log relationship between Cufflinks and Cuffdiff outputs.
Honey, how did you run Cufflinks? RABT mode or simple "quantification" mode? How long are the genes with super-high RPKM?
It seems to me that Cufflinks has a tendency to report super-high RPKM for very short transcripts (such as microRNA). I now routinely filter out the transcripts shorter than the expected fragment size (from the GTF annotation file). I think there is a good rationale to filter them out, because they can not be accurately captured by the RNA-Seq protocol....
In RABT mode, Cufflinks also reports a large number of short transcripts with crazy high values. A solution could be to re-quantify the discovered transcripts with something like BEDtools or HTSeq-count...
So you mean probably count method is better?
Comment
-
-
This issue has been discussed elsewhere on this board. As Nicholas points out, RNA-Seq really isn't reliable for very short transcripts. The reason is that all the fragments that map to these transcripts come from the "tail" of the distribution of library fragment lengths. That is, fragments that map to microRNAs are much, much shorter than most fragments in the library - by design in the RNA-Seq protocol, which size selects away very short inserts. Thus, Cufflinks infers that even though relatively few fragments actually mapped to the microRNAs, there were probably TONS of individual microRNA molecules in the transcriptome before all of the various size selection parts of the protocol kicked in. Cufflinks accordingly increases the FPKM of these short transcripts to compensate for the bias against short fragments in the library.
This compensation was designed to improve accuracy for transcripts that are in the 500bp-1kb range - for longer transcripts, the "edge effects" due to library fragment size aren't much of an issue. However, I wouldn't trust FPKM values for transcripts shorter than your average fragment length. There's really just not enough data in most standard RNA-Seq libraries to say much about small RNA abundance.
I should also point out that other methods use this same bias correction technique (RSEM for example). As far as I'm aware, the "count-based" methods don't, but that doesn't mean they shouldn't. Most of those methods are strictly for differential analysis, where any edge effects are assumed to be affecting each condition the same way. That may or may not be the case in your data.
In any case, the quick answer to this problem is to simply remove or ignore transcripts shorter than around 300bp from your GTF. In a future version, we will be flagging these transcripts as too short for reliable quantification where appropriate.
Comment
-
-
Hi Cole, Thanks for your post. I keep reading your comments here which are useful for many including me. I asked a similar question, with a twist, here: http://seqanswers.com/forums/showthread.php?t=17992
Can you comment please. In short, it is about how to deal with larger(>300 bp) transcripts with high FPKMs.
Originally posted by Cole Trapnell View PostThis issue has been discussed elsewhere on this board. As Nicholas points out, RNA-Seq really isn't reliable for very short transcripts. The reason is that all the fragments that map to these transcripts come from the "tail" of the distribution of library fragment lengths. That is, fragments that map to microRNAs are much, much shorter than most fragments in the library - by design in the RNA-Seq protocol, which size selects away very short inserts. Thus, Cufflinks infers that even though relatively few fragments actually mapped to the microRNAs, there were probably TONS of individual microRNA molecules in the transcriptome before all of the various size selection parts of the protocol kicked in. Cufflinks accordingly increases the FPKM of these short transcripts to compensate for the bias against short fragments in the library.
This compensation was designed to improve accuracy for transcripts that are in the 500bp-1kb range - for longer transcripts, the "edge effects" due to library fragment size aren't much of an issue. However, I wouldn't trust FPKM values for transcripts shorter than your average fragment length. There's really just not enough data in most standard RNA-Seq libraries to say much about small RNA abundance.
I should also point out that other methods use this same bias correction technique (RSEM for example). As far as I'm aware, the "count-based" methods don't, but that doesn't mean they shouldn't. Most of those methods are strictly for differential analysis, where any edge effects are assumed to be affecting each condition the same way. That may or may not be the case in your data.
In any case, the quick answer to this problem is to simply remove or ignore transcripts shorter than around 300bp from your GTF. In a future version, we will be flagging these transcripts as too short for reliable quantification where appropriate.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
211 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
78 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Comment